Sacubitril metabolite-13C4 is a labeled enzymatic breakdown product of sacubitril primarily used in the field of biomedical research It originates from the metabolism of sacubitril a neprilysin inhibitor involved in heart failure management The metabolite targets neprilysin pathways which play a critical role in the degradation of natriuretic peptides thereby influencing blood pressure regulation and fluid balance In vitro its activity typically ranges from nanomolar to low micromolar concentrations demonstrating significant engagement with biological pathways This compound is often applied in various experimental models including cell cultures and animal studies for drug screening purposes It aids in the investigation of pharmacokinetics and dynamics of neprilysin inhibition Experimental concentrations typically depend on the specific research design allowing for flexibility in different study parameters